Literature DB >> 16969644

Induction of the chemokine interferon-gamma-inducible protein-10 in human pancreatic islets during enterovirus infection.

A-K Berg1, O Korsgren, G Frisk.   

Abstract

AIMS/HYPOTHESIS: Enterovirus infections have long been suspected to be environmental factors that may cause type 1 diabetes, but the pathways leading from infection to beta cell destruction are still unknown. We therefore examined whether enterovirus infection of human islets leads to upregulation of interferon-gamma-inducible protein (IP-10, now known as chemokine [C-X-C motif] ligand 10 [CXCL10]), a chemokine important for the induction of insulitis.
METHODS: Isolated human islets were infected with three different strains of Coxsackie B4 virus. IP-10 expression and secretion from the infected human islets were then measured using RT-PCR and ELISA at several time points.
RESULTS: IP-10 was clearly upregulated in and secreted from human islets during enterovirus infection. This was demonstrated with three different strains of Coxsackie B4 virus, two of which are lytic to islets and one which is non-lytic and can establish a persistent infection in human islets. CONCLUSIONS/
INTERPRETATION: We propose that enterovirus-induced upregulation of IP-10 during infection of the islets in vivo is the first step towards destructive insulitis. Our findings support the idea that enterovirus infection triggers immune-mediated beta cell destruction, and for the first time suggest a possible mechanism behind enterovirus-induced diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969644     DOI: 10.1007/s00125-006-0429-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

2.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

3.  A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport.

Authors:  Els Wessels; Daniël Duijsings; Richard A Notebaart; Willem J G Melchers; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.

Authors:  Hong Yin; Anna-Karin Berg; Jan Westman; Claes Hellerström; Gun Frisk
Journal:  J Med Virol       Date:  2002-12       Impact factor: 2.327

5.  Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset.

Authors:  Hong Yin; Anna-Karin Berg; Torsten Tuvemo; Gun Frisk
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

Review 6.  IP-10 and type 1 diabetes: a question of time and location.

Authors:  Urs Christen; Matthias G von Herrath
Journal:  Autoimmunity       Date:  2004-06       Impact factor: 2.815

7.  Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease.

Authors:  Urs Christen; Dorian B McGavern; Andrew D Luster; Matthias G von Herrath; Michael B A Oldstone
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

8.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

9.  Encephalomyocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent mRNA translation.

Authors:  Aleksey G Aminev; Svetlana P Amineva; Ann C Palmenberg
Journal:  Virus Res       Date:  2003-09       Impact factor: 3.303

10.  Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus.

Authors:  H F Champsaur; G F Bottazzo; J Bertrams; R Assan; C Bach
Journal:  J Pediatr       Date:  1982-01       Impact factor: 4.406

View more
  11 in total

1.  Intravital imaging of CTLs killing islet cells in diabetic mice.

Authors:  Ken Coppieters; Natalie Amirian; Matthias von Herrath
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 2.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.

Authors:  H Scholz; T Lund; M K Dahle; J L Collins; O Korsgren; J E Wang; A Foss
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

4.  Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients.

Authors:  U Pugazhenthi; K Velmurugan; A Tran; G Mahaffey; S Pugazhenthi
Journal:  Diabetologia       Date:  2010-07-16       Impact factor: 10.122

5.  Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes.

Authors:  Bilal A Omar; Liu Liehua; Yuchiro Yamada; Yutaka Seino; Piero Marchetti; B Ahrén
Journal:  Diabetologia       Date:  2014-06-18       Impact factor: 10.122

Review 6.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

7.  Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.

Authors:  P Ylipaasto; T Smura; P Gopalacharyulu; A Paananen; T Seppänen-Laakso; S Kaijalainen; H Ahlfors; O Korsgren; J R T Lakey; R Lahesmaa; L Piemonti; M Oresic; J Galama; M Roivainen
Journal:  Diabetologia       Date:  2012-09-16       Impact factor: 10.122

Review 8.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

9.  Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment.

Authors:  Mara Kornete; Edward S Mason; Ciriaco A Piccirillo
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-25       Impact factor: 5.555

10.  Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Authors:  Shoichiro Tanaka; Yoriko Nishida; Kaoru Aida; Taro Maruyama; Akira Shimada; Masako Suzuki; Hiroki Shimura; Soichi Takizawa; Masashi Takahashi; Daiichiro Akiyama; Sayaka Arai-Yamashita; Fumihiko Furuya; Akio Kawaguchi; Masahiro Kaneshige; Ryohei Katoh; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2009-07-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.